Open3.000 | Close- |
Vol / Avg.3.554K / 10.039K | Mkt Cap4.952M |
Day Range3.000 - 3.120 | 52 Wk Range2.760 - 7.170 |
Medigus Stock (NASDAQ: MDGS) stock price, news, charts, stock research, profile.
Open3.000 | Close- |
Vol / Avg.3.554K / 10.039K | Mkt Cap4.952M |
Day Range3.000 - 3.120 | 52 Wk Range2.760 - 7.170 |
H1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | ||||||
REV | 53.385M |
FY 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.400 | ||||||
REV | 91.858M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2020-10-22 | Aegis Capital | - | Initiates Coverage On | Buy | Announces | - | 6.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
MDGS | Medigus | 0.64% | 5.3M |
NDRA | ENDRA Life Sciences | 0.73% | 11.8M |
POAI | Predictive Oncology | -7.6% | 12.4M |
VAPO | Vapotherm | 3.69% | 13.8M |
BJDX | Bluejay Diagnostics | 9.64% | 4.1M |
You can purchase shares of Medigus (NASDAQ: MDGS) through any online brokerage.
Other companies in Medigus’s space includes: ENDRA Life Sciences (NASDAQ:NDRA), Predictive Oncology (NASDAQ:POAI), Vapotherm (NYSE:VAPO), Bluejay Diagnostics (NASDAQ:BJDX) and Nexalin Technology (NASDAQ:NXL).
The latest price target for Medigus (NASDAQ: MDGS) was reported by Aegis Capital on Thursday, October 22, 2020. The analyst firm set a price target for 6.00 expecting MDGS to rise to within 12 months (a possible 92.31% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Medigus (NASDAQ: MDGS) is $3.1199 last updated Today at December 7, 2023 at 5:15 PM UTC.
There is no dividend information for Medigus.
Medigus’s H1 earnings are confirmed for Thursday, September 28, 2023.
There is no upcoming split for Medigus.
Medigus is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.